Share
2 years ago
U.S. approves first gene-editing treatment, Casgevy, for sickle cell disease
2 years ago
FDA Approves World's First Crispr Gene-Editing Drug for Sickle-Cell Disease
2 years ago
US regulators approve two gene therapies for sickle cell disease
2 years ago
US approves CRISPR gene-editing to treat sickle cell disease
Tags: First Crispr Gene-Editing Drug, FDA Approves World, U.S., regulators, Casgevy, gene therapies, CRISPR gene-editing, treatment, sickle cell disease, Sickle-Cell Disease, US,
Enter your email to subscribe to news alerts
Subscribe
←Top Latest Headlines